Likely, patients with overweight or obesity need to express higher amounts of ACE2 in their tissues to counteract their overactive RAS, and therefore, being more sensitive to the harmful effects of a potential reduction of tissular ACE2 levels after SARS‐CoV‐2 infection. The gene discussed is ACE2; the disease is obesity due to melanocortin 4 receptor deficiency.